Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Invion ( (AU:IVX) ) just unveiled an announcement.
Invion Limited has announced that it will hold its Extraordinary General Meeting (EGM) virtually on May 9, 2025. The meeting will allow shareholders to participate and vote in real-time, ensuring accessibility and engagement. This virtual format aligns with recent legislative changes and reflects Invion’s commitment to modernizing shareholder interactions. The company encourages shareholders to submit questions in advance and to register for the meeting online, emphasizing the importance of proxy voting.
More about Invion
Invion Limited is a company operating in the biopharmaceutical industry, focusing on the development of treatments for chronic inflammatory diseases. The company is listed on the Australian Securities Exchange (ASX) under the ticker IVX.
YTD Price Performance: -28.00%
Average Trading Volume: 1,000
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.89M
For a thorough assessment of IVX stock, go to TipRanks’ Stock Analysis page.